Results 1 to 10 of about 181,555 (164)

Clinical Effects of Vitamin D on the Control of Bronchial Asthma-Is it Relevant? [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Bronchial asthma is one of the most common chronic respiratory disease worldwide, and is characterised by different phenotypic variations. Acute exacerbations in bronchial asthma are common and leads to repeated hospitalisations leading to increase in ...
Gajanan S Gaude   +2 more
doaj   +1 more source

The causes and consequences of seasonal variation in COPD exacerbations [PDF]

open access: yes, 2014
Gavin C Donaldson, Jadwiga A Wedzicha Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK Abstract: The time of year when patients experience exacerbations of chronic obstructive pulmonary disease is a much ...
Donaldson, G, Wedzicha, J
core   +2 more sources

Risk factors for acute exacerbations of COPD in a primary care population: A retrospective observational cohort study [PDF]

open access: yes, 2014
Objectives: To evaluate risk factors associated with exacerbation frequency in primary care. Information on exacerbations of chronic obstructive pulmonary disease (COPD) has mainly been generated by secondary care-based clinical cohorts.
Hawkins, A   +3 more
core   +3 more sources

Practical Recommendations for a Selection of Inhaled Corticosteroids in COPD: A Composite ICO Chart

open access: yesBiomolecules, 2023
The use of inhaled corticosteroids (ICS) for the maintenance of bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD) is controversial.
Keiji Oishi   +5 more
doaj   +1 more source

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease [PDF]

open access: yes, 2010
Background Combination therapy (inhaled corticosteroids and long-acting beta(2)-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD).
Appleton   +20 more
core   +1 more source

LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE [PDF]

open access: yesJournal of IMAB, 2020
Purpose: To assess the efficacy of Azithromycin on exacerbations in patients with chronic obstructive pulmonary disease (COPD) and history of two or more flare-ups in the last 12 months and to study the influence of concomitant bronchiectasis on its ...
Vanya Kostadinova   +3 more
doaj   +1 more source

Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations [PDF]

open access: yes, 2018
The United Kingdom National Review of Asthma Deaths (NRAD) recommends that patients who require ≥3 courses of oral corticosteroids (OCS) for exacerbations in the past year or those on British Thoracic Society (BTS) Step 4/5 treatment must be referred to ...
Barclay, Stephen   +12 more
core   +2 more sources

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model. [PDF]

open access: yes, 2016
Exacerbations are a hallmark of chronic obstructive pulmonary disease (COPD). Evidence suggests the presence of substantial between-individual variability (heterogeneity) in exacerbation rates.
Albert, Richard   +8 more
core   +1 more source

Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults [PDF]

open access: yes, 2009
BackgroundThe measurement of severity and control of asthma in both children and adults can be based on subjective or objective measures. It has been advocated that fractional exhaled nitric oxide (FeNO) can be used to monitor airway inflammation as it ...
American Thoracic Society   +30 more
core   +4 more sources

Home - About - Disclaimer - Privacy